ReviewAntioxidants (Basel, Switzerland)2020

Patent Review (2017-2020) of the Keap1/Nrf2 Pathway Using PatSeer Pro: Focus on Autoimmune Diseases.

Dionysios V Chartoumpekis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.